Skip to main content

Key Product Details

Species Reactivity

Mouse

Applications

Western Blot

Label

FITC (Excitation = 495 nm, Emission = 519 nm)

Antibody Source

Polyclonal Goat IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant mouse Osteoadherin/OSAD
Gln21-Ile423
Accession # O35103

Specificity

Detects mouse Osteoadherin/OSAD in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 10% cross‑reactivity with recombinant human OSAD is observed.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Applications for Osteoadherin/OSAD/OMD Antibody [FITC]

Application
Recommended Usage

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: Osteoadherin/OSAD

OMD may be implicated in the biomineralization processes. It has a function in binding of osteoblasts via the alpha(V)beta(3)-integrin.

Alternate Names

OMD, OSAD, SLRR2C

Gene Symbol

OMD

Additional Osteoadherin/OSAD Products

Product Documents for Osteoadherin/OSAD/OMD Antibody [FITC]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Osteoadherin/OSAD/OMD Antibody [FITC]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...